JP2024512425A5 - - Google Patents
Info
- Publication number
- JP2024512425A5 JP2024512425A5 JP2023555630A JP2023555630A JP2024512425A5 JP 2024512425 A5 JP2024512425 A5 JP 2024512425A5 JP 2023555630 A JP2023555630 A JP 2023555630A JP 2023555630 A JP2023555630 A JP 2023555630A JP 2024512425 A5 JP2024512425 A5 JP 2024512425A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- treating
- compound according
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163160292P | 2021-03-12 | 2021-03-12 | |
| US63/160,292 | 2021-03-12 | ||
| PCT/US2022/020196 WO2022192781A1 (en) | 2021-03-12 | 2022-03-14 | Phenalkylamines and methods of making and using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024512425A JP2024512425A (ja) | 2024-03-19 |
| JP2024512425A5 true JP2024512425A5 (https=) | 2025-03-24 |
| JP7849377B2 JP7849377B2 (ja) | 2026-04-21 |
Family
ID=80999639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555630A Active JP7849377B2 (ja) | 2021-03-12 | 2022-03-14 | フェンアルキルアミン、並びにこれを作製及び使用する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240166618A1 (https=) |
| EP (1) | EP4305019A1 (https=) |
| JP (1) | JP7849377B2 (https=) |
| KR (1) | KR20240019063A (https=) |
| CN (1) | CN117642379A (https=) |
| AU (1) | AU2022234444A1 (https=) |
| BR (1) | BR112023018237A2 (https=) |
| CA (1) | CA3213289A1 (https=) |
| IL (1) | IL305834A (https=) |
| MX (1) | MX2023010711A (https=) |
| WO (1) | WO2022192781A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4460489A4 (en) * | 2022-01-04 | 2026-04-08 | Bright Minds Biosciences Inc | PHENETHYLAMINES AND THEIR PREPARATION PROCESSES |
| WO2023205116A1 (en) * | 2022-04-19 | 2023-10-26 | Gilgamesh Pharmaceuticals, Inc. | Pyridine derivatives for treating psychiatric disorders |
| AR130467A1 (es) * | 2022-09-12 | 2024-12-11 | Gilgamesh Pharmaceuticals Inc | Fenalquilaminas y métodos para fabricar y usar las mismas |
| WO2025085701A1 (en) * | 2023-10-18 | 2025-04-24 | Gilgamesh Pharmaceuticals, Inc. | Pyridine derivatives for treating psychiatric disorders |
| CN119827467B (zh) * | 2025-01-10 | 2026-03-24 | 中国科学技术大学 | 酰亚胺类化合物用于阿片类毒品的光激活荧光检测方法 |
| CN120271454B (zh) * | 2025-04-01 | 2026-01-06 | 衢州凯沃化工有限公司 | 一种光催化合成含七氟异丙基取代的苯胺化合物的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643310A1 (de) * | 1966-12-29 | 1971-06-03 | Dow Chemical Co | 4-Alkyl-2,5-dimethoxy-alpha-methyl-phenaethylamin und seine pharmakologisch vertraeglichen Salze |
| TW200744567A (en) * | 2005-09-23 | 2007-12-16 | Alcon Inc | Phenylethylamine analogs and their use for treating glaucoma |
-
2022
- 2022-03-14 JP JP2023555630A patent/JP7849377B2/ja active Active
- 2022-03-14 KR KR1020237034789A patent/KR20240019063A/ko active Pending
- 2022-03-14 CA CA3213289A patent/CA3213289A1/en active Pending
- 2022-03-14 WO PCT/US2022/020196 patent/WO2022192781A1/en not_active Ceased
- 2022-03-14 EP EP22714085.2A patent/EP4305019A1/en active Pending
- 2022-03-14 MX MX2023010711A patent/MX2023010711A/es unknown
- 2022-03-14 IL IL305834A patent/IL305834A/en unknown
- 2022-03-14 AU AU2022234444A patent/AU2022234444A1/en active Pending
- 2022-03-14 BR BR112023018237A patent/BR112023018237A2/pt unknown
- 2022-03-14 CN CN202280034218.1A patent/CN117642379A/zh active Pending
- 2022-03-14 US US18/281,127 patent/US20240166618A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024512425A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| JP2025013344A5 (https=) | ||
| JP2020534270A5 (https=) | ||
| JP2022171666A5 (https=) | ||
| JP2022537047A5 (https=) | ||
| JP2024528127A5 (https=) | ||
| JP2022545835A5 (https=) | ||
| JP2021529829A5 (https=) | ||
| JP2019507781A5 (https=) | ||
| JP2025060958A5 (https=) | ||
| JP2013532658A5 (https=) | ||
| JP2021535147A5 (https=) | ||
| JP2013522230A5 (https=) | ||
| JP2008505857A5 (https=) | ||
| JP2023523569A5 (https=) | ||
| JP2022531251A5 (https=) | ||
| JP2007536277A5 (https=) | ||
| JPWO2023195530A5 (https=) | ||
| JP2025502064A5 (https=) | ||
| JP2023524039A5 (https=) | ||
| JP2024516359A5 (https=) | ||
| JP2022551691A5 (https=) | ||
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases |